Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

What "newest" means here

The most recent study in this library is dated 2026-11-01 (Paths of Aging Minds: Health Journeys of Older Adults with Mild Cognitive Impairment). This is our summary library, not a news wire — it is added to in batches, so the newest entry may not be the newest paper published anywhere.

Entries are sorted strictly by publication date, newest first. 26489 of the 27380 entries carry a full day-level date. 65 have no date recorded at all and are placed by publication year, at the start of that year; those are marked "no date recorded" below so you can see where the ordering is a best effort rather than a fact.

Prefer a reader? Subscribe to the Atom feed. Want them sorted by subject or by score instead? Browse the research library.

Showing 201–225 of 27,380 studies, newest first · page 9 of 1096.

October 2026 25

  1. 2026-10-12

    Surrogate variables and the risk of overfitting in neuropsychiatric gene expression analyses

    ⚠ Preprint — not yet peer-reviewed Digital health tools bioRxiv

    Key finding: The reproducibility crisis in biomedical research calls for re-evaluation of how common analytic approaches affect results. +2 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  2. 2026-10-12

    PDE4D inhibition activates cAMP-PKA signaling to preserve mitochondrial homeostasis and prevent neuronal necroptosis in Alzheimer's disease

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms Research Square

    Key finding: Knocking down PDE4D in two mouse models significantly improved learning and memory, while reducing Aβ 1−42 deposition and tau phosphorylation. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  3. 2026-10-12

    An astrocyte-neuron HSPB1 axis preserves lysosomal integrity and protects from tau pathology

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms Research Square

    Key finding: Molecular chaperones are essential to prevent protein aggregation and, although typically studied as intracellular proteins, chaperones can also be secreted with functions that remain to be elucidated. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  4. 2026-10-12

    ALS-associated mutations reveal a conserved C-terminal self-assembly module in the TDP-43 low-complexity domain

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology bioRxiv

    Key finding: TAR DNA-binding protein 43 (TDP-43) is an RNA-binding protein whose low-complexity domain (LCD) mediates self-assembly, liquid-liquid phase separation, and pathological aggregation associated with amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). +1 more finding

    Scored 27 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  5. 2026-10-12

    Upper cervical spinal cord morphometric charts: from population references to individualized clinical assessment

    ⚠ Preprint — not yet peer-reviewed Vascular contributions medRxiv

    Key finding: These deviation scores captured disease-specific abnormalities, enabled disease classification, and were associated with cognition, physical disability and disease progression. +1 more finding

    Scored 31 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  6. 2026-10-12

    Social participation diversity and cognitive trajectories in older adults with hypertension and diabetes: a longitudinal cohort study

    ⚠ Preprint — not yet peer-reviewed Prevention trials Research Square

    Key finding: Greater diversity of social participation was associated with better long-term cognitive maintenance among older adults with hypertension and/or diabetes. +4 more findings

    Scored 44 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  7. 2026-10-12

    Interpretable Frequency-Aware Deep Learning for Multi-Class EEG Classification of Neurological Disorders

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging Preprints.org

    Key finding: The model filters each EEG window into the delta, theta, alpha, beta, and gamma bands and processes every band in a separate convolutional branch with squeeze-and-excitation recalibration. +4 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  8. 2026-10-12

    Disease-Specific Perturbational Convergence Between Genetic-Risk and Disease-State Transcriptomic Signatures in Alzheimer's Disease

    ⚠ Preprint — not yet peer-reviewed Genetics Research Square

    Key finding: In the present analysis, genetic risk and end-stage AD pathology are largely decoupled at the level of individual genes and pathways but converge on a shared, pharmacologically modifiable response landscape.

    Scored 31 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  9. 2026-10-12

    A rapid, genetically-tractable human iPSC-derived model for studying tissue-resident macrophage biology in Alzheimer’s and other diseases

    ⚠ Preprint — not yet peer-reviewed Genetics bioRxiv

    Key finding: Robust TREM2 expression and signaling make iMacs a sensitive platform for interrogating TREM2 biology, with markedly higher phosphorylation of SYK and PLCγ2 in response to TREM2 engagement compared to iPSC-derived microglia. iMacs also tolerate lipid-mediated siRNA transfection with high survival and knockdown efficiency, enabling rapid genetic perturbation of AD risk genes.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  10. 2026-10-12

    Mechanistic study of PHLDA1 in cognitive dysfunction of Alzheimer’s disease model mice via FoxO1‑mediated neuroinflammation

    ⚠ Preprint — not yet peer-reviewed Biomarkers Research Square

    Key finding: Collectively, the PHLDA1–FoxO1–TLR4 axis may significantly influence AD neuroinflammation, and targeting PHLDA1 provides a rationale for developing anti-inflammatory therapeutic strategies against AD.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  11. 2026-10-12

    Symptom-Guided Blood Biomarker Testing for Alzheimer's Disease

    ✓ Peer-reviewed Biomarkers Dementia and geriatric cognitive disorders

    Key finding: Trial Parent study registrations: NCT01231971; NCT02854033. +1 more finding

  12. 2026-10-11

    Electronic Health Record-Based Machine Learning Models for Predicting Revascularization, Amputation, and Cardiovascular Mortality in At-Risk Patients

    ⚠ Preprint — not yet peer-reviewed Digital health tools Research Square

    Key finding: Patients with peripheral artery disease (PAD), chronic limb-threatening ischemia (CLTI), and/or diabetic foot ulcer (DFU) are at increased risk for limb loss and death. +2 more findings

    Scored 40 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  13. 2026-10-11

    EEG Pathology Detection via Clinical Concept Bottleneck Models

    ⚠ Preprint — not yet peer-reviewed Digital health tools bioRxiv

    Key finding: Both CBMs approach the baseline on TUAB (82.7–82.9% vs 83.6%) and are 2–5 percentage points lower on CAUEEG (57.9–60.5% vs 62.7%). +4 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  14. 2026-10-11

    Subtype-Selective Neuronal Vulnerability and Compensatory Neuroglial Remodeling in Human Cortical Dementia

    ⚠ Preprint — not yet peer-reviewed Disease mechanisms bioRxiv

    Key finding: In DLPFC we observed alteration of mitochondrial and synaptic maintenance program in the pathological manifestation of disease. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  15. 2026-10-11

    α-Synuclein Seeding Activity in Fixed Antemortem Skin Biopsies From Patients With Synucleinopathies

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology Research Square

    Key finding: Seeding readouts correlated with Hoehn and Yahr stage but not significantly with MoCA score or pS129 α-synuclein burden.

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  16. 2026-10-11

    Carbonaceous Components Underlying Wildfire Smoke PM 2.5 -Associated Alzheimer’s Disease and Related Dementias in Older US Adults

    ⚠ Preprint — not yet peer-reviewed Risk factors medRxiv

    Key finding: Per 1 µg/m 3 increase, smoke PM 2.5 was associated with incident AD (hazard ratio [HR], 1.015, 95% confidence interval [CI], 1.005-1.026) and ADRD (1.029 [1.024-1.035]). +3 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  17. 2026-10-11

    The influence of cognitive decline on the severity and quantity of drug-drug interactions

    ⚠ Preprint — not yet peer-reviewed Risk factors Research Square

    Key finding: These findings indicate that cognitive impairment may mark a population vulnerable to medication complexity rather than independently driving DDI risk, with polypharmacy emerging as the principal modifiable determinant. +3 more findings

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  18. 2026-10-11

    A large, comprehensive labeled MRI dataset of the human lateral ventricle choroid plexus

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging bioRxiv

    Key finding: However, limitation in the accuracy of the current segmentation tools highlight the need for more reliable methods to quantify ChP volume in healthy and clinical human populations. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  19. 2026-10-11

    Continuous amyloid staging complements global amyloid burden in early Alzheimer’s disease

    ⚠ Preprint — not yet peer-reviewed Brain scans and imaging bioRxiv

    Key finding: A continuous amyloid staging score complements global amyloid burden for early AD staging and cognitive risk stratification. +1 more finding

    Scored 35 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  20. 2026-10-11

    DAP12-deficient microglia adopt a TREM2-independent antigen-presenting state with a glial-to-neuronal cascade in Nasu-Hakola disease

    ⚠ Preprint — not yet peer-reviewed TREM2 and immune genetics bioRxiv

    Key finding: TREM2-DAP12 is the switch that converts microglia from a surveillant to a reactive state; what DAP12-deficient microglia become and to what extent they reshape their microenvironment is unknown. +4 more findings

    Scored 24 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  21. 2026-10-11

    Expression predictions inform molecular interpretation of Alzheimer’s disease risk loci

    ⚠ Preprint — not yet peer-reviewed Genetics medRxiv

    Key finding: Expression and splicing scores were associated with the corresponding Genotype-Tissue Expression (GTEx) quantitative trait locus (QTL) status, although these analyses did not establish colocalization or agreement in allelic direction. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  22. 2026-10-11

    Mapping polygenic risk scores to brain cells: insights for neurodegenerative diseases

    ⚠ Preprint — not yet peer-reviewed Genetics medRxiv

    Key finding: We found substantial overlap among purportedly cell-type specific gene sets (21-29%), with APOE or neighbouring genes from the APOE locus represented in all gene sets, indicating that current cell-type specific annotations capture considerable shared genetic variation across cell-types. +1 more finding

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  23. 2026-10-11

    Clinical utility of plasma APOE proteotyping for Alzheimer’s disease risk and prognosis

    ⚠ Preprint — not yet peer-reviewed Genetics medRxiv

    Key finding: Plasma APOE4 proteotyping accurately distinguished genotype-defined APOE ε4 carrier status and copy number while demonstrating AD-related associations comparable to DNA genotyping.

    Scored 32 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  24. 2026-10-10

    Identifying Individualized Multiple Chronic Condition Pathways Associated with Dementia

    ⚠ Preprint — not yet peer-reviewed Digital health tools Preprints.org

    Key finding: Unlike traditional eager decision trees (eagerDT), which lacked sufficient training data for 17%-33% of patient profiles, lazyDT-MCCPath successfully modeled all profiles and achieved a 0.17 improvement in AUROC (0.66 vs. 0.83). lazyDT-MCCPath effectively translates pre-existing MCC profiles into personalized dementia risk probabilities for emerging conditions, which may help clinicians prioritize MCCs to monitor more closely.

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

  25. 2026-10-10

    ASC specks and α-synuclein amplify microglial NLRP3 inflammasome activation and co-localize with Lewy body pathology

    ⚠ Preprint — not yet peer-reviewed Brain tissue and pathology bioRxiv

    Key finding: Neuroinflammation is a hallmark of several chronic neurodegenerative disorders, including Parkinson’s disease (PD) and other synucleinopathies, and is closely associated with microglial activation. +4 more findings

    Scored 21 on our rubric, shown as 16: non-peer-reviewed sources are capped at 16. See the breakdown.

Browse the library by subject, with the full score breakdown →